Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lumexa Imaging HoldingsLMRI -0.36%8 Debt-to-Equity is 1.61 as of Mar. 2026, which is 76% below its 10-year median of 6.58. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 704 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks worse than 92.47% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Lumexa Imaging Holdings's Debt-to-Equity or its related term are showing as below:
LMRI'
s Debt-to-Equity Range Over the Past 10 Years
Min: 1.61 Med: 6.58 Max: 8.1
Current: 1.61
During the past 3 years, the highest Debt-to-Equity Ratio of Lumexa Imaging Holdings was 8.10. The lowest was 1.61. And the median was 6.58.
LMRI's Debt-to-Equity is ranked worse than 92.47% of 704
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs LMRI: 1.61
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Lumexa Imaging Holdings Debt-to-Equity Related Terms
Lumexa Imaging Holdings Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LMRI vs AVNS, AORT, IRMD: Debt-to-Equity Comparison
For the Medical Devices subindustry, Lumexa Imaging Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a Debt-to-Equity of 1.61 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Lumexa Imaging Holdings and its competitors. This is 76% below median its historical median of 6.58. Over the past decade, Lumexa Imaging Holdings' Debt-to-Equity has ranged from 1.61 to 8.10. According to the industry distribution chart, Lumexa Imaging Holdings ranks #651 out of 704 companies in the Medical Devices & Instruments industry, placing it in the top 92.5%.
Is Lumexa Imaging Holdings' Debt-to-Equity too high?
Lumexa Imaging Holdings' current Debt-to-Equity of 1.61 is 76% below median its 10-year median of 6.58. Over the past 10 years, this metric has ranged from a low of 1.61 to a high of 8.10. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Lumexa Imaging Holdings' value of 1.61 is 600% above this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #651 out of 704 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' Debt-to-Equity compare to AVNS and AORT?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #651 out of 704 companies for Debt-to-Equity. This places Lumexa Imaging Holdings in the lower half of its industry. The industry median Debt-to-Equity is 0.23. Lumexa Imaging Holdings' value of 1.61 is 600% above this benchmark. Historically, Lumexa Imaging Holdings' own Debt-to-Equity has ranged from 1.61 to 8.10 over the past decade. While the company's 10-year median is 6.58 vs. the industry median of 0.23, Lumexa Imaging Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current Debt-to-Equity of 1.61 is 600% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Lumexa Imaging Holdings and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current Debt-to-Equity is 1.61, which is 76% below median its own 10-year median of 6.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current Debt-to-Equity of 1.61. The current Debt-to-Equity is 1.61, which is 76% below median its 10-year median of 6.58 and 600% above the Medical Devices & Instruments industry median of 0.23. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current Debt-to-Equity is 1.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score
Get the complete analysis for LMRI
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 
